| pubmed-article:17290189 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17290189 | lifeskim:mentions | umls-concept:C0023810 | lld:lifeskim |
| pubmed-article:17290189 | lifeskim:mentions | umls-concept:C1411976 | lld:lifeskim |
| pubmed-article:17290189 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:17290189 | lifeskim:mentions | umls-concept:C1621958 | lld:lifeskim |
| pubmed-article:17290189 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:17290189 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
| pubmed-article:17290189 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17290189 | pubmed:dateCreated | 2007-2-9 | lld:pubmed |
| pubmed-article:17290189 | pubmed:abstractText | Toll-like receptor 4 (Tlr-4) mediates many biological effects of lipopolysaccharide (LPS), which has antitumoral effects on glioblastoma both in vivo and in vitro. However, the precise role of Tlr-4 in these antitumoral effects remains unknown. | lld:pubmed |
| pubmed-article:17290189 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17290189 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290189 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17290189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290189 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17290189 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17290189 | pubmed:issn | 1524-4040 | lld:pubmed |
| pubmed-article:17290189 | pubmed:author | pubmed-author:PerryArieA | lld:pubmed |
| pubmed-article:17290189 | pubmed:author | pubmed-author:HigashikuboRy... | lld:pubmed |
| pubmed-article:17290189 | pubmed:author | pubmed-author:ChicoineMicha... | lld:pubmed |
| pubmed-article:17290189 | pubmed:author | pubmed-author:WonEun... | lld:pubmed |
| pubmed-article:17290189 | pubmed:author | pubmed-author:KitamuraTetsu... | lld:pubmed |
| pubmed-article:17290189 | pubmed:author | pubmed-author:ZahnerMichael... | lld:pubmed |
| pubmed-article:17290189 | pubmed:author | pubmed-author:KalraRicky... | lld:pubmed |
| pubmed-article:17290189 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17290189 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:17290189 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17290189 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17290189 | pubmed:pagination | 372-80; discussion 381 | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:meshHeading | pubmed-meshheading:17290189... | lld:pubmed |
| pubmed-article:17290189 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17290189 | pubmed:articleTitle | The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4. | lld:pubmed |
| pubmed-article:17290189 | pubmed:affiliation | Department of Neurosurgery, Washington University School of Medicine, Saint Louis, Missouri 63110, USA. mchicoine@POL.net | lld:pubmed |
| pubmed-article:17290189 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17290189 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290189 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290189 | lld:pubmed |
